Abstract
It is axiomatic that, before any product is placed on the market, there must exist convincing evidence that during the time between its manufacture and its use by the consumer it will not undergo any change that will adversely affect its performance, render it less acceptable to the consumer or cause it to represent a risk to the user. That is, it must be known to have an adequate shelf-life.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Grimm, W. (1985/6) Drugs Made in Germany: (1985) 28, 196–202 and (1986) 29, 39–47.
Commission of the European Communities (1989) The Rules Governing Medicinal Products in the European Community, vol. III: Guidelines on the Quality, Safety and Efficacy of Medicinal Products for Human Use (Luxembourg: EC).
Editor information
Rights and permissions
Copyright information
© 2000 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Cannell, J.S. (2000). Stability testing. In: Butler, H. (eds) Poucher’s Perfumes, Cosmetics and Soaps. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-2734-1_23
Download citation
DOI: https://doi.org/10.1007/978-94-017-2734-1_23
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-4034-3
Online ISBN: 978-94-017-2734-1
eBook Packages: Springer Book Archive